Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2-Positive Breast Cancer

• Κύριοι συγγραφείς: Miaomiao Jia (Συγγραφέας), Haibo Yang (Συγγραφέας), Lihui Pan (Συγγραφέας), Jinnan Gao (Συγγραφέας), Fan Guo (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Hindawi-Wiley, 2024-01-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Conclusion: HER2 IHC 2+ may indicate a decreased tpCR rate, bpCR rate, and apCR rate to neoadjuvant treatment in HR-positive patients having HER2-positive breast cancer, but not in HR-negative patients.